Learn more about the clinical dilemma that arises when treating patients with atrial fibrillation who present with acute coronary syndrome (ACS) and/or require percutaneous coronary intervention (PCI). What are the limitations of the antithrombotic strategies currently recommended for the treatment of this group of patients and how are these being addressed?
Find out how the antithrombotic strategies currently recommended for this group of patients might be falling short.
Using a unique study design, the AUGUSTUS trial addressed two of the most important unanswered questions regarding the treatment of patients with atrial fibrillation who present with acute coronary syndrome (ACS) and/or require percutaneous coronary intervention (PCI). In this interactive module, discover how insights from this study could bring us one step closer to optimisation of antithrombotic strategies in this challenging group of patients.
Developed by EPG Health for Medthority. This content has been developed independently of the sponsors who have had no editorial input into the content. Medthority received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.